+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Integrilin"

Integrilin - API Insight, 2022 - Product Thumbnail Image

Integrilin - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Integrilin- Drug Insight, 2019 - Product Thumbnail Image

Integrilin- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Integrilin is a cardiovascular drug used to treat and prevent blood clots. It is a glycoprotein IIb/IIIa inhibitor, meaning it works by blocking the action of a certain protein that helps platelets in the blood stick together and form clots. It is used to treat unstable angina, non-ST-segment elevation myocardial infarction, and coronary artery bypass grafting. It is also used to prevent blood clots in patients undergoing percutaneous coronary intervention. Integrilin is available in both intravenous and subcutaneous forms. Integrilin is a widely used drug in the cardiovascular market, with many companies offering it. Some of these companies include Pfizer, Merck, Bristol-Myers Squibb, and AstraZeneca. Show Less Read more